GlaxoSmithKline Pharmaceuticals Limited GlaxoSmithKline Pharmaceuticals Limited

GlaxoSmithKline Pharmaceuticals Limited

GLAXO

शेयरों में रैंक #3776
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
शेयर मूल्य
$25.73
मार्केट कैप
$4.36B
बदलाव (1 दिन)
-5.33%
बदलाव (1 वर्ष)
-17.92%
देश
IN
व्यापार GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

श्रेणी

Healthcare
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $28.33 (2026-10-01 को)

दिन का सबसे निम्न समापन मूल्य: $7.46 (1999-01-01 को)
GlaxoSmithKline Pharmaceuticals Limited के स्टॉक मूल्य का इतिहास 1999 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) -0.80%
2025 3.53%
2024 30.13%
2023 28.84%
2022 -31.26%
2021 11.05%
2020 -8.11%
2019 15.01%
2018 5.68%
2017 -5.61%
2016 -18.58%
2015 0.11%
2014 11.37%
2013 16.93%
2012 5.11%
2011 -25.99%
2010 39.42%
2009 47.96%
2008 -8.92%
2007 -0.02%
2006 7.37%
2005 41.03%
2004 38.71%
2003 85.99%
2002 3.08%
2001 -33.62%
2000 -42.61%
1999 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$1.31K 61.21%
US
$268.35 39.08%
US
$284.58 24.44%
US
$147.45 68.30%
US
$482.01 30.76%
CH